Repro Med Systems, Inc. (KRMD)

NASDAQ: KRMD · IEX Real-Time Price · USD
2.47
+0.01 (0.61%)
Jun 24, 2022 3:50 PM EDT - Market closed
0.61%
Market Cap 110.60M
Revenue (ttm) 24.30M
Net Income (ttm) -5.82M
Shares Out 44.87M
EPS (ttm) -0.13
PE Ratio n/a
Forward PE 188.68
Dividend n/a
Ex-Dividend Date n/a
Volume 54,578
Open 2.44
Previous Close 2.45
Day's Range 2.32 - 2.59
52-Week Range 1.82 - 4.72
Beta 0.40
Analysts Buy
Price Target 4.42 (+79.3%)
Earnings Date Aug 10, 2022

About KRMD

Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It s... [Read more...]

Industry Health Care Equipment & Supplies
Founded 1980
Employees 77
Stock Exchange NASDAQ
Ticker Symbol KRMD
Full Company Profile

Financial Performance

In 2021, KRMD's revenue was $23.49 million, a decrease of -2.84% compared to the previous year's $24.18 million. Losses were -$4.56 million, 276.5% more than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for KRMD stock is "Buy." The 12-month stock price forecast is 4.42, which is an increase of 79.31% from the latest price.

Price Target
$4.42
(79.31% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Repro Med Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates

Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 16.67% and 4.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

KORU Medical Systems Announces 2022 First Quarter Financial Results

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufa...

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label ...

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufa...

KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of inno...

KORU Medical Systems Appoints Brian Case As Chief Technology Officer

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of inno...

Repro Med Systems, Inc. (KRMD) Reports Q4 Loss, Tops Revenue Estimates

Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 5.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

KORU Medical Systems Announces 2021 Q4 and Full Year Financial Results

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufa...

Analysts Estimate Repro Med Systems, Inc. (KRMD) to Report a Decline in Earnings: What to Look Out for

Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March ...

CHESTER, N.Y.--(BUSINESS WIRE)--First paragraph, first sentence of release dated February 16, 2022, should read: Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “C...

KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2021

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of inno...

KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of inno...

KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of inno...

Repro Med Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates

Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 10.44%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

KORU Medical Systems Announces 2021 Third Quarter Financial Results

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufa...

KORU Medical Announces FDA Clearance for Delivery of Hizentra® Prefilled Syringes

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufa...

KORU Medical Systems to Participate in Two Upcoming Conferences

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of inno...

KORU Medical Announces Collaboration With Gilero to Accelerate Innovation

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufa...

KORU Medical Expands Senior Team to Accelerate Growth Strategy

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of inno...

KORU Medical Systems to Report Third Quarter 2021 Financial Results on November 10, 2021

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufa...

Earnings Preview: Repro Med Systems, Inc. (KRMD) Q3 Earnings Expected to Decline

Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

KORU Medical Appoints Chris Pazdan as Vice President of Quality Assurance and Regulatory Affairs

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of inno...

Repro Med Systems, Inc. (KRMD) Reports Q2 Loss, Tops Revenue Estimates

Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 10.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

KORU Medical Systems Announces 2021 Second Quarter Financial Results

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufa...

KORU Medical Systems to Participate in Canaccord Genuity's 41st Annual Growth Conference

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufa...

KORU Medical Systems to Report Second Quarter 2021 Financial Results on August 11, 2021

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufa...